Antitumor Activity of a Novel Oncrasin Analogue Is Mediated by JNK Activation and STAT3 Inhibition

Wei Guo(The University of Texas MD Anderson Cancer Center), Bingliang Fang(The University of Texas MD Anderson Cancer Center)

PLoS ONE

December 12, 2011

10.1371/journal.pone.0028487

Cited by 32

Related Papers

Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells

|Oncotarget|2015|147

Oxidative stress in NSC-741909-induced apoptosis of cancer cells

|Journal of Translational Medicine|2010|51

Insulin-Like Growth Factor Binding Protein-2 Level Is Increased in Blood of Lung Cancer Patients and Associated with Poor Survival

|PLoS ONE|2013|45

<scp>KIAA1429</scp> regulates lung adenocarcinoma proliferation and metastasis through the <scp>PI3K</scp>/<scp>AKT</scp> pathway by modulating <scp>ARHGAP30</scp> expression

|Thoracic Cancer|2024|8